Epidemiology and Histology Aspects of Breast Cancers of Women in Ivory Coast
786
sarcomas) in our country. This is a situation due to the
impact of the virus HIV/AIDS, most often responsible
for carcinogenesis of tumor whose incidence remains
high in Ivorian society [16]. Primitive non-Hodgkin lym-
phomas have also been identified; the most common is
an endemic Burkitt lymphoma (68% of cases). Indeed,
the incidence of lymphoma B is high in African countries
located under the Sahara. In Coast Ivory, it particularly
affects children and adolescents and represents for 30 to
60% of childhood cancers with a predominant localiza-
tion in the mandible [17]. These locations extra-atypical
mandibular and abdominal are rare in the literature and
could be due to a spreading of tumor cells from an un-
known site to the mammary vessels. The high rate of
breast cancers among patients under 30 years observed in
our study is related to the impact of these two endemic
diseases in Ivory Coast.
5. Conclusion
Breast cancer is a common disease in the Ivory Coast and
is therefore a major public health problem. It is a disease
that primarily affects young individuals and is most often
diagnosed at an advanced stage. In consideration of the
poor prognosis of breast cancer of women in our country,
an effort should be made for the setting up of information
programs and training of women (breast self-examina-
tion), health workers and medical practitioners (gyne-
cologists) throughout the territory. The effectiveness of
such a public health program must take into account both
the training of specialists in pathology, and the creation
of a radiotherapy and oncology equipped structure as part
of a real testing policy of precancerous lesions and their
management.
REFERENCES
[1] World Health Organization (WHO 2008), “The Global
Burden of Disease,” 2004 Update.
[2] H. Rochefort and J. Rouëssé, “Breast Cancer: Incidence
and Prevention,” Report of a Working Group of Commit-
tee III (Cancer), 2000, p. 22.
[3] I. Diomandé, A. F. D’Horpock, P. Heroin, M. Ette, A.
Dago, F. Battesti, et al., “Evolution of Cancer in Ivory
Coast,” Medical Publication in Iv ory Coast, Vol. 75, 1988,
pp. 81-84.
[4] A. Echimane, A. Ahnoux, I. Adoubi, S. Hien, K. M’Bra,
A. F. D’Horpock, et al., “Cancer Incidence in Abidjan,
Ivory Coast. First Results from the Cancer Registry,
1995-1997,” Cancer, Vol. 89, No. 3, 2000, pp. 653-663.
doi:10.1002/1097-0142(20000801)89:3<653::AID-CNCR
22>3.0.CO;2-Z
[5] M. Traore, F. S. Diabate, I. Diarra, N. Mounkoro, Y.
Traore, I. Tekété, et al., “Breast and Gynecologic Cancer
at the Hospital from the Point G in Bamako,” Medical
Publication in Mali, Vol. 19, No. 2, 2004, pp. 4-9.
[6] D. Sano, R. Cissé, B. Dao, J. Lankoandé, S. S. Traore, R.
B. Soudré, et al., “Breast Cancer, Diagnostic and Thera-
peutic Problems at the Hospital of Ouagadougou,” Medi-
cal Publication in Subsaharan Africa, Vol. 45, No. 5,
1998, pp. 297-301.
[7] H. Najjar and A. Easson, “Age at Diagnosis of Breast
Cancer in Arab Nations,” International Journal of Sur-
gery, 2010, [Epub ahead of print].
[8] C. R. Raharisolo Vol.olonantenaina, L. P. Rabarijiaona, C.
Rajemiarimoeisoa, M. Rasendramino and R. Migliani,
“Assessment of Breast Cancers Diagnosed L’institut Pas-
teur de Madagascar from 1995 to 2001,” Archives de
L’Institut Pasteur de Madagascar, Vol. 68, 2002, pp.
104-108.
[9] D. Shaheenah, B. Kristine, A. Gonzalez, A. U. Busdor, N.
Hortobagyi and H. G. Sharon, “Trends in Survival over
the Past Two Decades among White in Black Patients
with Newly Diagnosed Internship IV Breast Cancer,”
Journal of Clinical Oncology, Vol. 26, No. 30, 2008, pp.
4889-4899.
[10] C. A. Adebamowo, S. N. Akarolo-Anthony and O. O.
Temiayo, “Emerging Epidermic Breast Cancer: Evidence
from Africa,” Breast Cancer Research, Vol. 12, Suppl. l
4, 2010, p. S8. doi:10.1186/bcr2737
[11] A. Antoniou, P. D. Pharoah, S. Narod, H. A. Risch, J. E.
Eyfjord, J. L. Hopper, et al., “Average Risks of Breast
and Ovarian Cancer Associated with BRCA1 or BRCA2
Mutations Detected in Case Series Unselected for Family
History: A Combined Analysis of 22 Studies,” Erratum in:
The Am eri c an J o urn al of Human Genetics, Vol. 73, No. 3,
2003, p. 709.
[12] C. M. Friedenreich and M. R. Orenstein, “Physical Activ-
ity and Cancer Prevention: Etiologic Evidence and Bio-
logical Mechanisms,” Journal of Nutrition, Vol. 132, No.
11, 2002, pp. 3456S-3664S.
[13] World Health Organization, “Tumors of the Breast and
the Female Genital Organs,” In: P. Deviled, Ed., Pathol-
ogy and Genetics, IARC Press, Lyon, 2003, pp. 13-59.
[14] A. Laplanche and E. Benhamou, “Estimated Incidence of
Cancer in France,” Bull Cancer, Vol. 78, No. 5, 1991, pp.
505-514.
[15] E. Duarte-Franco and E. L. Franco, “Others Gynecologic
Cancers: Endometrial, Ovarian, and Vaginal Cancers
Vulva,” BMC Women’s Health, Vol. 25, Suppl. l1, 2004,
S14. doi:10.1186/1472-6874-4-S1-S14
[16] D. M. Parkin, S. L. Whelan, J. Ferlay, L. Raymond and J.
Young, “Cancer in Five Continents,” IARC Scientific
Publications, Lyon, Vol. 12, No. 143, 1997, pp. 35-36.
[17] A. B. Effi, K. J. N’Dah, A. A. N’Guiessan, B. Doukouré,
M. Kouyaté, A. D. Abouna, et al., “Epidemiology and
Pathology of Carcinoma in Ivory Coast,” African Journal
of Cancer, Vol. 4, 2012, pp. 41-47.
doi:10.1007/s12558-011-0189-2
Copyright © 2012 SciRes. JCT